Literature DB >> 3075551

Endothelin has potent inotropic effects in rat atria.

J R Hu1, R Von Harsdorf, R E Lang.   

Abstract

Endothelin, a novel peptide recently isolated from aortic endothelial cells, is one of the most active vasoconstrictors yet characterized. We report that endothelin is also a very potent inotropic substance, as demonstrated in isolated rat heart atria. The effects were observed at nanomolar concentrations and appeared to be due to a direct action of the peptide on the heart muscle cells. Thus, endothelin is not only a powerful vasoconstrictor but also has potent contractile effects on cardiac myocytes.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3075551     DOI: 10.1016/0014-2999(88)90079-9

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  16 in total

1.  Pharmacological characteristics of endothelin receptors in the rabbit ventricular myocardium: the nonselective endothelin receptor antagonist PD 145065 antagonizes the positive inotropic effect of endothelin-3 but not of endothelin-1.

Authors:  I Norota; M Endoh
Journal:  Mol Cell Biochem       Date:  1996 Jul-Aug       Impact factor: 3.396

Review 2.  Endothelin: a review of its effects and possible mechanisms of action.

Authors:  W Lovenberg; R C Miller
Journal:  Neurochem Res       Date:  1990-04       Impact factor: 3.996

3.  Inhibition of endothelin- and phorbol ester-stimulated tyrosine kinase activity by corticotrophin in the rat adrenal zona glomerulosa.

Authors:  S Kapas; J P Hinson
Journal:  Biochem J       Date:  1996-02-01       Impact factor: 3.857

4.  Inositol phosphate release and steroidogenesis in rat adrenal glomerulosa cells. Comparison of the effects of endothelin, angiotensin II and vasopressin.

Authors:  E A Woodcock; P J Little; J K Tanner
Journal:  Biochem J       Date:  1990-11-01       Impact factor: 3.857

5.  Streptozotocin-induced diabetes reduces the density of [125I]-endothelin-binding sites in rat cardiac membranes.

Authors:  W G Nayler; J J Liu; S Panagiotopoulos; D J Casley
Journal:  Br J Pharmacol       Date:  1989-08       Impact factor: 8.739

6.  Effects of moderate hypoxia, hypercapnia and acidosis on haemodynamic changes induced by endothelin-1 in the pithed rat.

Authors:  M R MacLean; M D Randall; C R Hiley
Journal:  Br J Pharmacol       Date:  1989-11       Impact factor: 8.739

7.  A low-affinity, low-molecular-mass endothelin-A receptor in neonatal rat heart.

Authors:  E A Woodcock; S L Land; R K Andrews; M Linsenmeyer; D M Woodcock
Journal:  Biochem J       Date:  1994-11-15       Impact factor: 3.857

8.  Effects of endothelin-1 on epicardial coronary tone, coronary blood flow, ECG-ST change and regional wall motion in anesthetized dogs.

Authors:  K Muramatsu; H Tomoike; Y Ohara; S Egashira; M Nakamura
Journal:  Heart Vessels       Date:  1991       Impact factor: 2.037

Review 9.  Endothelin and myocardial ischemia.

Authors:  D Hasdai; R Kornowski; A Battler
Journal:  Cardiovasc Drugs Ther       Date:  1994-08       Impact factor: 3.727

10.  Endothelin-1 inhibits L-type Ca currents enhanced by isoproterenol in guinea-pig ventricular myocytes.

Authors:  L H Xie; M Horie; A F James; M Watanuki; S Sasayama
Journal:  Pflugers Arch       Date:  1996-02       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.